These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 30012404)
1. Comparison of particle size methodology and assessment of nanoparticle tracking analysis (NTA) as a tool for live monitoring of crystallisation pathways. McComiskey KPM; Tajber L Eur J Pharm Biopharm; 2018 Sep; 130():314-326. PubMed ID: 30012404 [TBL] [Abstract][Full Text] [Related]
2. In situ monitoring of nanoparticle formation: Antisolvent precipitation of azole anti-fungal drugs. McComiskey KPM; Mugheirbi NA; Stapleton J; Tajber L Int J Pharm; 2018 May; 543(1-2):201-213. PubMed ID: 29604371 [TBL] [Abstract][Full Text] [Related]
3. Impact of polyethylene glycol polymers on the physicochemical properties and mucoadhesivity of itraconazole nanoparticles. Machado Cruz R; Santos-Martinez MJ; Tajber L Eur J Pharm Biopharm; 2019 Nov; 144():57-67. PubMed ID: 31493509 [TBL] [Abstract][Full Text] [Related]
4. Practical Considerations for Detection and Characterization of Sub-Micron Particles in Protein Solutions by Nanoparticle Tracking Analysis. Gruia F; Parupudi A; Polozova A PDA J Pharm Sci Technol; 2015; 69(3):427-39. PubMed ID: 26048748 [TBL] [Abstract][Full Text] [Related]
6. Heat induced evaporative antisolvent nanoprecipitation (HIEAN) of itraconazole. Mugheirbi NA; Paluch KJ; Tajber L Int J Pharm; 2014 Aug; 471(1-2):400-11. PubMed ID: 24879938 [TBL] [Abstract][Full Text] [Related]
7. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties. Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388 [TBL] [Abstract][Full Text] [Related]
8. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions. Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850 [TBL] [Abstract][Full Text] [Related]
9. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC. Wang X; Michoel A; Van den Mooter G Int J Pharm; 2004 Mar; 272(1-2):181-7. PubMed ID: 15019081 [TBL] [Abstract][Full Text] [Related]
10. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension. Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534 [TBL] [Abstract][Full Text] [Related]
11. Formulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability. Fadke J; Desai J; Thakkar H AAPS PharmSciTech; 2015 Dec; 16(6):1434-44. PubMed ID: 25991065 [TBL] [Abstract][Full Text] [Related]
12. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Filipe V; Hawe A; Jiskoot W Pharm Res; 2010 May; 27(5):796-810. PubMed ID: 20204471 [TBL] [Abstract][Full Text] [Related]
13. Impact of molecular rearrangement of amphiphilic stabilizers on physical stability of itraconazole nanoparticles prepared by flash nanoprecipitation. Wan KY; Wong KW; Chow AHL; Chow SF Int J Pharm; 2018 May; 542(1-2):221-231. PubMed ID: 29555440 [TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Mukherjee S; Ray S; Thakur RS Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221 [TBL] [Abstract][Full Text] [Related]
15. Mesophase and size manipulation of itraconazole liquid crystalline nanoparticles produced via quasi nanoemulsion precipitation. Mugheirbi NA; Tajber L Eur J Pharm Biopharm; 2015 Oct; 96():226-36. PubMed ID: 26264714 [TBL] [Abstract][Full Text] [Related]
16. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods. Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678 [TBL] [Abstract][Full Text] [Related]
17. Itraconazole suspension for intravenous injection: determination of the real component of complete refractive index for particle sizing by static light scattering. Wong J; Papadopoulos P; Werling J; Rebbeck C; Doty M; Kipp J; Konkel J; Neuberger D PDA J Pharm Sci Technol; 2006; 60(5):302-13. PubMed ID: 17089699 [TBL] [Abstract][Full Text] [Related]
18. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5. Janssens S; de Armas HN; Roberts CJ; Van den Mooter G J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067 [TBL] [Abstract][Full Text] [Related]
19. Interference from Proteins and Surfactants on Particle Size Distributions Measured by Nanoparticle Tracking Analysis (NTA). Bai K; Barnett GV; Kar SR; Das TK Pharm Res; 2017 Apr; 34(4):800-808. PubMed ID: 28155075 [TBL] [Abstract][Full Text] [Related]